Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of Safety and Efficacy of PDP-716

ClinicalTrials.gov ID: NCT03450629

Public ClinicalTrials.gov record NCT03450629. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-Center, Investigator-Masked, Parallel Group, Equivalence Study of Once Daily Brimonidine Tartrate Ophthalmic Suspension Compared With Three Times Daily ALPHAGAN-P® in Subjects With Open Angle Glaucoma, or Ocular Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will be conducted to evaluate the efficacy and safety of topical administration of PDP-716 compared with brimonidine tartrate ophthalmic solution.

Study identification

NCT ID
NCT03450629
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
682 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 13, 2018 (Actual)
Primary completion
Dec 1, 2020 (Actual)
Completion
Dec 1, 2020 (Actual)
Last update posted
Feb 15, 2022

2018 – 2020

United States locations

U.S. sites
47
U.S. states
17
U.S. cities
40
Facility City State ZIP Site status
SPARC Site 4 Chandler Arizona 85225 —
SPARC Site 5 Prescott Arizona 86301 —
SPARC Site 3 Sun City Arizona 85351 —
SPARC Site 38 Burbank California 91506 —
SPARC Site 44 Glendale California 91204 —
SPARC Site 45 Glendale California 91204 —
SPARC Site 43 Mission Hills California 91345 —
SPARC Site 1 Newport Beach California 92663 —
SPARC Site 14 Santa Barbara California 93110 —
SPARC Site 47 Torrance California 90505 —
SPARC Site 7 Colorado Springs Colorado 80919 —
SPARC Site 11 Coral Springs Florida 33067 —
SPARC Site 29 Deerfield Beach Florida 33064 —
SPARC Site 34 Fort Myers Florida 33901 —
SPARC Site 46 Hollywood Florida 33021 —
SPARC Site 21 Jacksonville Florida 32204 —
SPARC Site 35 Miami Florida 33126 —
SPARC Site 27 Miami Florida 33134 —
SPARC Site 10 Miami Florida 33143 —
SPARC Site 16 Miami Florida 33145 —
SPARC Site 19 Miami Florida 33174 —
SPARC Site 25 Miami Florida 33175 —
SPARC Site 41 Pompano Beach Florida 33060 —
SPARC Site 18 Tampa Florida 33603 —
SPARC Site 42 Atlanta Georgia 30349 —
SPARC Site 2 Morrow Georgia 30260 —
SPARC Site 22 Roswell Georgia 30076 —
SPARC Site 12 Chicago Illinois 60619 —
SPARC Site 23 Paducah Kentucky 42001 —
SPARC Site 40 Bowie Maryland 20715 —
SPARC Site 28 Kansas City Missouri 64055 —
SPARC Site 48 Kansas City Missouri 64133 —
SPARC Site 31 St Louis Missouri 63128 —
SPARC Site 15 Poughkeepsie New York 12603 —
SPARC Site 36 Rochester New York 14618 —
SPARC Site 30 Gastonia North Carolina 28054 —
SPARC Site 9 High Point North Carolina 27262 —
SPARC Site 17 Winston-Salem North Carolina 27101 —
SPARC Site 33 Fargo North Dakota 58103 —
SPARC Site 37 Cincinnati Ohio 45242 —
SPARC Site 8 Cleveland Ohio 44115 —
SPARC Site 24 Cranberry Township Pennsylvania 16066 —
SPARC Site 32 Memphis Tennessee 38119 —
SPARC Site 39 Houston Texas 77008 —
SPARC Site 13 Mission Texas 78572 —
SPARC Site 20 San Antonio Texas 78215 —
SPARC Site 26 Saint Albans Vermont 05478 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03450629, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 15, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03450629 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →